首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

BREAST
ISSN：0960-9776

BREAST

BREAST
学科领域：医学
是否预警：不在预警名单内
是否OA：是
录用周期：平均1月
新锐分区：医学2区
年发文量：135
影响因子：7.9
JCR分区：Q1

基本信息

《乳腺》是一本面向研究人员和临床医生的国际性多学科期刊，重点关注转化和临床研究，以促进乳腺癌预防、诊断和治疗的各个阶段。
0960-9776SCIE/Scopus收录/DOAJ开放期刊
7.9
点击查看最新影响趋势>
4.7
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
OBSTETRICS & GYNECOLOGY 妇产科学
1区
是
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：OBSTETRICS & GYNECOLOGY
SCIE
Q1
4/141
学科：ONCOLOGY
SCIE
Q1
40/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：OBSTETRICS & GYNECOLOGY
SCIE
Q1
9/141
学科：ONCOLOGY
SCIE
Q1
32/328
70
135
点击查看年发文量趋势图>
6%12%平均1月USD3520医学-妇产科学
2.5%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
92.59%99.28%1.9%
CiteScore：10.40
SJR：2.348
SNIP：2.108
学科类别分区排名百分位
大类：Medicine
小类：Surgery
Q1
9 / 568
大类：Medicine
小类：Oncology
Q1
56 / 415
大类：Medicine
小类：Cancer Research
Q1
50 / 233

期刊高被引文献

Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers.
来源期刊：BreastDOI：10.1016/j.breast.2019.07.001
Homologous recombination deficiency in triple negative breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.02.007
Long non-coding RNA HOTAIR in circulatory exosomes is correlated with ErbB2/HER2 positivity in breast cancer.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.003
Targeting CDK4/6 pathways and beyond in breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2018.10.001
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
来源期刊：BreastDOI：10.1016/j.breast.2019.07.006
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.010
Cancer treatment effects on cognition and depression: The moderating role of physical activity.
来源期刊：BreastDOI：10.1016/j.breast.2019.01.004
Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.009
Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.011
Postmastectomy radiotherapy in T1-2 patients with one to three positive lymph nodes - Past, present and future.
来源期刊：BreastDOI：10.1016/j.breast.2019.09.008
Low eicosapentaenoic acid and gamma-linolenic acid levels in breast adipose tissue are associated with inflammatory breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.001
Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study.
来源期刊：BreastDOI：10.1016/j.breast.2019.01.003
Effects of pessimism, depression, fatigue, and pain on functional health-related quality of life in patients with resected non-advanced breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.01.012
Patient-reported health problems and healthcare use after treatment for early-stage breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.03.010
Consumer and clinician perspectives on personalising breast cancer prevention information.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.002
Peptide vaccines in early breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.02.003
Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries.
来源期刊：BreastDOI：10.1016/j.breast.2019.09.004
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.008
Results of PONDx, a prospective multicenter study of the Oncotype DX® breast cancer assay: Real-life utilization and decision impact in French clinical practice.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.015
Pathways to care for patients in Pakistan experiencing signs or symptoms of breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.005
Meta-analysis of long-term efficacy and safety of hypofractionated radiotherapy in the treatment of early breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.08.001
The changes of quality of life and their correlations with psychosocial factors following surgery among women with breast cancer from the post-surgery to post-treatment survivorship.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.011
Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study.
来源期刊：BreastDOI：10.1016/j.breast.2019.09.010
Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?
来源期刊：BreastDOI：10.1016/j.breast.2019.05.009
A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.010
Breast cancer medical malpractice litigation in New York: The past 10\u202fyears.
来源期刊：BreastDOI：10.1016/j.breast.2019.03.009
Towards mm-wave spectroscopy for dielectric characterization of breast surgical margins.
来源期刊：BreastDOI：10.1016/j.breast.2019.02.008
Lymph node infiltration, parallel metastasis and treatment success in breast cancer.
来源期刊：BreastDOI：10.1016/j.breast.2019.07.008
Prepectoral direct-to-implant breast reconstruction with complete ADM or synthetic mesh coverage - 36-Months follow-up in 200 reconstructed breasts.
来源期刊：BreastDOI：10.1016/j.breast.2019.08.002
Endoscopic-assisted surgery in the management of breast cancer: 20 years review of trend, techniques and outcomes.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.013
Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.04.003
Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansine.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.011
Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.007
Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands.
来源期刊：BreastDOI：10.1016/j.breast.2019.08.004
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.004
Is trastuzumab as a single agent obsolete in early breast cancer? No.
来源期刊：BreastDOI：10.1016/j.breast.2018.09.002
Changes in employment status up to 5 years after breast cancer diagnosis: A prospective cohort study.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.07.007
De-escalation of complexity in oncoplastic breast surgery: Case series from a specialized breast center.
来源期刊：BreastDOI：10.1016/j.breast.2019.04.002
Safety of menopausal hormone therapy in breast cancer survivors older than fifty at diagnosis: A systematic review and meta-analysis.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.06.002
Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16).
来源期刊：BreastDOI：10.1016/j.breast.2019.02.010
Patient-reported fatigue in breast cancer patients receiving radiation therapy.
来源期刊：BreastDOI：10.1016/j.breast.2019.06.004
Adjuvant radiation therapy in small ductal carcinoma in situ.
来源期刊：BreastDOI：10.1016/j.breast.2018.11.004
Breast cancer follow-up after a primary diagnosis: A confused picture.
来源期刊：BreastDOI：10.1016/J.BREAST.2019.05.010
Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV.
来源期刊：BreastDOI：10.1016/j.breast.2018.12.005

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
OBSTETRICS & GYNECOLOGY 妇产科学
1区
是
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
OBSTETRICS & GYNECOLOGY 妇产科学
2区
ONCOLOGY 肿瘤学
2区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
OBSTETRICS & GYNECOLOGY 妇产科学
2区
ONCOLOGY 肿瘤学
3区
否
否